Cargando…

MIEAP and ATG5 are tumor suppressors in a mouse model of BRAF(V600E)-positive thyroid cancer

Mitochondria-eating protein (MIEAP) is a molecule important for non-canonical mitophagy and thought to be a tumor suppressor. Our previous study found that MIEAP expression is defective in thyroid oncocytomas, irrespective of being benign or malignant, and also in non-oncocytic thyroid cancers. Thyr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamada, Koichiro, Kurashige, Tomomi, Shimamura, Mika, Arakawa, Hirofumi, Nakamura, Yasuyuki, Nagayama, Yuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519861/ https://www.ncbi.nlm.nih.gov/pubmed/36187114 http://dx.doi.org/10.3389/fendo.2022.932754

Ejemplares similares

Discovery of Mieap‐regulated mitochondrial quality control as a new function of tumor suppressor p53
por: Nakamura, Yasuyuki, et al.
Publicado: (2017)

Mouse models of sporadic thyroid cancer derived from BRAF(V600E) alone or in combination with PTEN haploinsufficiency under physiologic TSH levels
por: Shimamura, Mika, et al.
Publicado: (2018)

Mieap suppresses murine intestinal tumor via its mitochondrial quality control
por: Tsuneki, Masayuki, et al.
Publicado: (2015)

Characterization of metabolic reprogramming by metabolomics in the oncocytic thyroid cancer cell line XTC.UC1
por: Kurashige, Tomomi, et al.
Publicado: (2023)

Cancer Stem Cells in the Thyroid
por: Nagayama, Yuji, et al.
Publicado: (2016)

Mieap, a p53-Inducible Protein, Controls Mitochondrial Quality by Repairing or Eliminating Unhealthy Mitochondria
por: Kitamura, Noriaki, et al.
Publicado: (2011)

BNIP3 and NIX Mediate Mieap-Induced Accumulation of Lysosomal Proteins within Mitochondria
por: Nakamura, Yasuyuki, et al.
Publicado: (2012)

Reevaluation of the Effect of Iodine on Thyroid Cell Survival and Function Using PCCL3 and Nthy-ori 3-1 Cells
por: Kurashige, Tomomi, et al.
Publicado: (2020)

Hormonal Regulation of Autophagy in Thyroid PCCL3 Cells and the Thyroids of Male Mice
por: Kurashige, Tomomi, et al.
Publicado: (2020)

Possible role of p53/Mieap‐regulated mitochondrial quality control as a tumor suppressor in human breast cancer
por: Gaowa, Siqin, et al.
Publicado: (2018)

Identification of 14-3-3γ as a Mieap-interacting protein and its role in mitochondrial quality control
por: Miyamoto, Takafumi, et al.
Publicado: (2012)

Differences in quantification of DNA double-strand breaks assessed by 53BP1/γH2AX focus formation assays and the comet assay in mammalian cells treated with irradiation and N-acetyl-L-cysteine
por: Kurashige, Tomomi, et al.
Publicado: (2016)

Risk Factors for Neck Nodal Metastasis in Papillary Thyroid Cancer With BRAF V600E Mutation
por: Han, Ying, et al.
Publicado: (2022)

Causative role for defective expression of mitochondria‐eating protein in accumulation of mitochondria in thyroid oncocytic cell tumors
por: Mussazhanova, Zhanna, et al.
Publicado: (2020)

Clinical Outcome, Role of BRAF(V600E), and Molecular Pathways in Papillary Thyroid Microcarcinoma: Is It an Indolent Cancer or an Early Stage of Papillary Thyroid Cancer?
por: Nucera, Carmelo, et al.
Publicado: (2012)

Association Between Preoperative US, Elastography Features and Prognostic Factors of Papillary Thyroid Cancer With BRAF(V600E) Mutation
por: Xu, Jun-Mei, et al.
Publicado: (2020)

How do BRAF(V600E) and TERT promoter mutations interact with the ATA and TNM staging systems in thyroid cancer?
por: Mukhtar, Noha, et al.
Publicado: (2023)

Mieap-regulated mitochondrial quality control is frequently inactivated in human colorectal cancer
por: Kamino, H, et al.
Publicado: (2016)

Radiomic Model for Determining the Value of Elasticity and Grayscale Ultrasound Diagnoses for Predicting BRAF(V600E) Mutations in Papillary Thyroid Carcinoma
por: Wang, Yu-guo, et al.
Publicado: (2022)

Correlation of the Expression of BRAF V600E Mutation With Various Phenotypic Expressions of Thyroid Neoplasms
por: Harikrishnan, Volga, et al.
Publicado: (2021)

Targeting BRAF(V600E) with PLX4720 Displays Potent Antimigratory and Anti-invasive Activity in Preclinical Models of Human Thyroid Cancer
por: Nucera, Carmelo, et al.
Publicado: (2011)

Commentary: Excessive Iodine Promotes Pyroptosis of Thyroid Follicular Epithelial Cells in Hashimoto's Thyroiditis Through the ROS-NF-κB-NLRP3 Pathway
por: Nagayama, Yuji
Publicado: (2020)

Predictive Factors of Recurrence for Multifocal Papillary Thyroid Microcarcinoma With Braf(v600e) Mutation: A Single Center Study of 1,207 Chinese Patients
por: Xue, Shuai, et al.
Publicado: (2019)

BRAF(V600E) Mutation-Responsive miRNA-222-3p Promotes Metastasis of Papillary Thyroid Cancer Cells via Snail-Induced EMT
por: Gao, Yuan, et al.
Publicado: (2022)

Reprogramming of Cellular Metabolism and Its Therapeutic Applications in Thyroid Cancer
por: Nagayama, Yuji, et al.
Publicado: (2022)

Fine Needle Biopsy Versus Core Needle Biopsy Combined With/Without Thyroglobulin or BRAF 600E Mutation Assessment for Detecting Cervical Nodal Metastasis of Papillary Thyroid Carcinoma
por: Zhang, Xiaojun, et al.
Publicado: (2021)

Redifferentiation of BRAF V600E-Mutated Radioiodine Refractory Metastatic Papillary Thyroid Cancer After Treatment With Dabrafenib and Trametinib
por: Jafri, Sabih, et al.
Publicado: (2021)

The Combined Utility of HBME-1 and Galectin-3 Immunohistochemistry and BRAF V600E Mutations in the Diagnosis of Papillary Thyroid Carcinoma
por: Ramkumar, Subramaniam, et al.
Publicado: (2021)

The Utility of BRAF Testing in the Management of Papillary Thyroid Cancer
por: Melck, Adrienne L., et al.
Publicado: (2010)

Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells with BRAF(V600E): New Insights in the Host Tissue Adaptation and Homeostasis of Tumor Microenvironment
por: Duquette, Mark, et al.
Publicado: (2013)

Corrigendum: Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells With BRAF(V600E): New Insights in the Host Tissue Adaptation and Homeostasis of Tumor Microenvironment
por: Duquette, Mark, et al.
Publicado: (2020)

Pathological and Prognostic Characterization of Craniopharyngioma Based on the Expression of TrkA, β-Catenin, Cell Cycle Markers, and BRAF V600E Mutation
por: Xu, Cheng, et al.
Publicado: (2022)

Thymic Adenocarcinoma with Positivity for Thyroid Transcription Factor-1 and a BRAF V600E Mutation
por: Yorozuya, Takafumi, et al.
Publicado: (2021)

Molecular mechanisms and physiological roles of Atg5/Atg7-independent alternative autophagy
por: ARAKAWA, Satoko, et al.
Publicado: (2017)

The BRAF(V600E) mutation: what is it really orchestrating in thyroid cancer?
por: Nucera, Carmelo, et al.
Publicado: (2010)

Clinical implication of the BRAF(V600E) mutation in papillary thyroid carcinoma
por: Kim, Yong-Seok, et al.
Publicado: (2013)

Prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma
por: HE, GUOPING, et al.
Publicado: (2014)

BRAF V600E and lymph node metastases in papillary thyroid cancer
por: Chen, Pan, et al.
Publicado: (2020)

Preoperative BRAF(V600E) mutation detection in thyroid carcinoma by immunocytochemistry
por: Swan, Kristine Zøylner, et al.
Publicado: (2022)

Prevalence and Impact of BRAF mutation in patients with concomitant papillary thyroid carcinoma and Hashimoto’s thyroiditis: a systematic review with meta-analysis
por: Janicki, Lukasz, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_efv9k08p2l0dl81eiclvv8odop